Search results
Results from the WOW.Com Content Network
If you’ve been keeping up with vaccine news over the past year, Ocugen (NASDAQ:OCGN) stock is a name that may not sound familiar. That’s because the company is not a vaccine manufacturer, but ...
The reason for investing in Ocugen (NASDAQ:OCGN) stock hasn’t changed. Bulls expect the FDA to allow Ocugen to market Bharat Biotech’s Covaxin vaccine in the U.S., enabling Ocugen to generate ...
For premium support please call: 800-290-4726 more ways to reach us
Ocugen (OCGN) is a latecomer to the coronavirus stock party. But in true latecomer fashion, it has made a dazzling entrance. Shares are up year-to-date by 544%, as investors have cheered on the ...
The successful prediction of a stock's future price could yield significant profit. The efficient market hypothesis suggests that stock prices reflect all currently available information and any price changes that are not based on newly revealed information thus are inherently unpredictable. Others disagree and those with this viewpoint possess ...
Since the start of its upward surge, I’ve been skeptical about Ocugen (NASDAQ:OCGN). Trading for far less than $1 per share for most of 2020, OCGN stock went into hyperdrive starting in late ...
Last year, I wrote that the most likely outcome for Ocugen (NASDAQ:OCGN) stock was that it would hit zero. Seven months later, OCGN stock is above $7 and Ocugen has a market capitalization well ...
I am all for a good opportunity, but I don't know why some investors insist on penny stocks. Names like Ocugen (NASDAQ:OCGN) aren't trading for about 50 cents apiece by accident. While it feels ...